Clinical Trial Update: Keppra IV for the Treatment of Motor Fluctuations in Parkinson's Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial of Keppra IV for motor fluctuations in Parkinson's Disease was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Keppra (levetiracetam)

Snippet

Sponsor: University of South Florida | Conditions: Parkinson's Disease | Phase 4 | Status: WITHDRAWN